Clinical trial
Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line…
NCT00079872 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00079872 |
|---|---|
| Title | Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer |
| Official title | A Randomized Phase 2 Trial of ALIMTA Plus a Comparator Versus Leucovorin Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Pemetrexed |
| Enrollment | 120 |
| Start date | Feb 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Mar 19, 2004 |
| Last update posted | Nov 6, 2007 |
| Countries | Australia, Germany, Greece, Netherlands, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: